Privately Held Drug Discovery Company, Canbas Co., Ltd. Raises $20 Million In 4th Round Financing

CanBas Co., Ltd. (“CanBas”), a privately held drug discovery company located in Numazu-city, Shizuoka, Japan, announced today that the company has raised approximately $20 million (JPY 2,359 million) in the 4th financing. This round, which closed November 30, 2005, was co-led by NIF SMBC Ventures and MVC (Mitsui Ventures). 24 other VC firms and 8 strategic investors, including Nikko antfactory, MBL Venture Capital, Mizuho Capital, Nomura Securities and Marubeni, participated in this round.

MORE ON THIS TOPIC